Search
for
Sort by
Research 931–960 of 1000+
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Male and female pattern hair loss
- The impact of 1-hour plasma glucose on the metabolic characteristics and pregnancy outcomes in polycystic ovary syndrome
- Exploring the Use of Topical Tofacitinib in Pediatric Alopecia Totalis
- Skin Related Problems Among Women of Reproductive Age Suffering from Polycystic Ovarian
- Progress on mitochondria and hair follicle development in androgenetic alopecia: relationships and therapeutic perspectives
- Signal integrator function of CXXC5 in Cancer
- Biochemical predictor for polycystic ovary syndrome
- Causal Relationship and Potential Common Pathogenic Mechanisms Between Alopecia Areata and Related Cancer
- Dermoscopic Features of Pili Annulati: Features of PA
- Ayurvedic management of systemic sclerosis - A case report
- Achalasia and hyperthyroidism: A co-occurrence revealing autoimmune connections
- Animals in Dermatology
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- Obstructive Sleep Apnea and Sleep Quality in Women with Polycystic Ovary Syndrome: A Cross-sectional Study
- The Association of Serum Ferritin Levels With Non-scarring Alopecia in Women
- Trichotillomania with Giant Gastric Trichobezoar in a Female Child: A Case Report
- TRICHOTILLOMANIA WITH GIANT GASTRIC TRICHOBEZOAR IN A FEMALE CHILD: A CASE REPORT
- [Translated article] Keys to the Diagnosis of Hair Shaft Disorders: Part II
- Co-occurrence of Progressive Hemifacial atrophy due to Morphea with homolateral segmental Vitiligo: a case report
- General Dermatology
- Generalised Glucocorticoid Resistance
- Treatment of hereditary hypotrichosis simplex of the scalp with oral minoxidil and growth factors
- Successful Therapy of Alopecia Universalis Using a Combination of Systemic Methotrexate and Corticosteroids and Topical 5% Minoxidil
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Current evaluation of amenorrhea
- Mendelian randomization study highlights hypothyroidism as a causal determinant of alopecia areata
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Risk Factors and Characterization of Vitiligo and Alopecia Areata in Patients With Chronic Graft-vs-Host Disease